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Radiographic Outcome and Complication Rate of 34
Graduates After Treatment With Vertical Expandable
Prosthetic Titanium Rib (VEPTR): A Single Center Report
Daniel Studer, MD,* Philippe Büchler, PhD,† and Carol C. Hasler, MD*
Background: The ﬁnal strategy for graduates from growth-
sparing surgery is challenging. The purpose of this study was to
evaluate the radiographic outcome and complications of patients
with early onset scoliosis (EOS) who have graduated from ver-
tical expandable prosthetic titanium rib (VEPTR) treatment,
either undergoing ﬁnal fusion surgery or following a nonfusion
approach.
Methods: Final treatment for VEPTR graduates was divided in
“VEPTR in situ without ﬁnal fusion,” “removal of VEPTR
without ﬁnal fusion,” and “removal of VEPTR with instrumented
ﬁnal fusion.” Radiographic evaluations included main coronal
Cobb angle and main kyphosis pre and post VEPTR implantation,
at the end of implant lengthening, after ﬁnal fusion (if applicable),
and at latest follow-up. Complications during VEPTR treatment
and in case of ﬁnal fusion were reported.
Results: In total, 34 VEPTR graduates were included; 17 under-
went ﬁnal fusion surgery, and 17 followed a nonfusion strategy.
Average coronal Cobb angle before VEPTR implantation was
70±23 degrees (range, 21 to 121 degrees), and 65±22 degrees
(range, 17 to 119 degrees) at latest follow-up. Average main ky-
phosis angle was 53±27 degrees (range, 6 to 137 degrees) before
VEPTR, and 69±34 degrees (range, 10 to 150 degrees) at latest
follow-up. There was a 41% complication rate with ﬁnal fusion
surgery.
Conclusions: There is a high complication rate during VEPTR
treatment and with ﬁnal fusion surgery. The stiffness of the spine
and thorax allow for only limited correction when performing a
ﬁnal instrumented spondylodesis. Avoiding ﬁnal fusion may be
a viable alternative in case of good coronal and sagittal alignment.
Level of Evidence: Level IV—therapeutic.
Key Words: early onset scoliosis, spinal fusion, growth-sparing
surgery
(J Pediatr Orthop 2019;39:e731–e736)
Over the past 3 decades different growth-sparing sur-gical techniques have emerged, replacing the habit of
early operative spinal fusion in patients with early onset
scoliosis (EOS). According to the classiﬁcation of growth
sparing implants provided by Skaggs et al,1 the use of
distraction-based systems has been favored, focusing on
optimizing pulmonary development by controlling the
spinal deformity and stimulating the growth of the spine,
thorax and lungs.2,3 Although, there is current consensus
to use bilateral spine-based implants such as traditional
(tGR) or magnetically controlled growing rods (MCGR)
in case of absence of thoracic insufﬁciency syndrome
(TIS), the use of rib-based implants appeared attractive
with the introduction of the vertical expandable prosthetic
titanium rib (VEPTR) technique. This approach allows
for indirect spine-sparing control of deformities.4–7 This
initial enthusiasm continuously declined with the number
of studies reporting on high complication rates as well as
ossiﬁcations along the implant and across ribs, even in
case of a formerly normal thorax.8–11 For these reasons,
the use of VEPTR should be limited to the indications
directed by the inventor, Dr. Robert Campbell Jr, namely
for patients with congenital EOS and/or in case of TIS.
Despite many reports on growth friendly implants,
there is paucity of description regarding the ﬁnal strategy
for EOS patients at the end of growth. Flynn et al12 in
2013 were the ﬁrst ones to report on a multicenter series of
99 graduates from growing rod (GR) treatment. Two
other reports from the Growing Spine Study Group
(GSSG) focused on EOS patients after tGR13 and Shilla
growth guidance treatment,14 the former focusing on the
possibility of avoiding ﬁnal surgical fusion. Johnston
et al15 reported on functional and radiographic outcomes
of 12 patients following growth sparing management, in-
cluding one VEPTR patient, and Sawyer et al16 looked at
complications and radiographic outcomes of 37 patients
after distraction-based treatment, whereof 32 had rib-
based ﬁxation without speciﬁcation of the type of implant.
To determine the incidence and causes of reoperations
after ﬁnal fusion, Poe-Kochert et al17 reported on 100
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patients with a minimum follow-up of 2 years for tGR
graduates after ﬁnal fusion surgery. A recent study fo-
cusing on the decision-making process of EOS graduates
included 23 tGR and 5 VEPTR patients,18 and Lattig
et al19 reported on a case series of 5 VEPTR graduates. To
our knowledge our study represents the largest cohort of
patients after growth sparing treatment with VEPTR.
The aim of this study was to gain additional in-
formation on how to conﬁgure the ﬁnal treatment strategy
for EOS patients who have graduated from VEPTR
treatment. Scaling down the knowledge gap of when to
stop growth sparing treatment and decide on performing
or avoiding ﬁnal fusion surgery should further improve the
quality of care in this challenging ﬁeld of pediatric or-
thopaedics.
METHODS
After getting approval from the institutional ethical
review board, the hospital’s surgical database was
screened for all EOS patients treated with VEPTR. Pa-
tients were excluded in case of incomplete medical records
or ongoing growth sparing treatment. The etiology of the
deformity was classiﬁed using the C-EOS classiﬁcation.20
Final treatment was divided in “VEPTR in situ without
ﬁnal fusion,” “removal of VEPTR without ﬁnal fusion,”
and “removal of VEPTR with ﬁnal instrumented fusion.”
Patients who had undergone ﬁnal fusion surgery were
further subdivided in case of use of preoperative halo-
gravity traction. Radiographic measures included major
curve’s Cobb angle and main kyphosis assessment pre and
post VEPTR implantation, at the end of implant length-
ening, after ﬁnal fusion surgery (if applicable), as well as at
latest follow-up. In case of preoperative halo-gravity
traction before ﬁnal fusion, the major curve’s Cobb angle
and the main kyphosis at the end of the traction period
were also documented. Complications during VEPTR
treatment and in case of ﬁnal fusion surgery were classiﬁed
as implant-related, infections, and others. The severity of
the complications was classiﬁed as proposed by Smith
et al.21 In addition, age at VEPTR implantation, duration
of VEPTR treatment, number of lengthenings, as well as
the length of follow-up was documented.
Statistics
Data are presented as the mean±SD together with
its range; from its minimum to its maximum value.
Measurements were compared with unpaired t tests when
normally distributed. The Wilcoxon signed rank-sum test
was used to compare non-normally distributed variables.
Shapiro-Wilk tests were used to verify a normal dis-
tribution of samples. P-values were 2-sided, and P= 0.05
was considered the threshold for statistical signiﬁcance.
All statistical analyses were performed using the open-
source statistical package R (http://www.r-project.org/).
RESULTS
Between April 2002 and June 2013, 55 patients
underwent VEPTR instrumentation for EOS at our
institution; 21 patients had to be excluded; 11 patients are
still under growth sparing treatment, and 10 patients had
incomplete medical records (3 died during the lengthening
period because of their comorbidities, 6 foreign patients
had further treatment in their home country, and one
patient had a VEPTR inserted as a salvage procedure). In
total, 34 VEPTR patients had graduated from growth
sparing treatment and were eligible for evaluation. Dem-
ographics and etiologies of VEPTR graduates are listed in
Table 1. In 4 patients, the index operation was performed
after the age of 10. All of them had a congenital etiology
of scoliosis diagnosed before the age of 10. With intended
6-monthly intervals a total of 347 implant lengthenings
were performed.
The mean age at the end of VEPTR treatment was
13.8±2.3 years (range, 9.6 to 19.6 y). The mean time be-
tween the last VEPTR lengthening and the latest follow-up
was 50±25 months (range, 10 to 115mo).The main coronal
Cobb angle before the index operation averaged 70±23
degrees (range, 21 to 121 degrees), reducing to 50±22 de-
grees (range, 10 to 107 degrees) after VEPTR implantation,
and being 65±22 degrees (range, 17 to 119 degrees) after
the last lengthening (Fig. 1). The main kyphosis averaged
53±27 degrees (range, 6 to 137 degrees) preoperative,
changing to 43±23 degrees (range, 5 to 95 degrees)
immediately postoperative, and 70±33 degrees (range, 15
to 133 degrees) after the last lengthening.
17 VEPTR graduates followed a nonfusion ﬁnal
strategy. In 5 patients with congenital EOS and unilateral
constructs the implants were simply removed. Their mean
follow-up period was 39±16 months (range, 19mo to 59mo).
The average major curve and kyphosis angles at the end of
lengthening for this group were 54 degrees and 50 degrees
Cobb angle, respectively. In 12 patients the VEPTR was left
in situ. The mean follow-up for this group was 43±25 months
TABLE 1. Etiologies and Demographics of Patients Graduated
From VEPTR Treatment
Male Female Total
VEPTR graduates 19 15 34
Etiology of EOS
Idiopathic 1 0 1
Neuromuscular 4 5 9
Congenital 11 7 18
Syndromic 1 3 4
Thoracogenic 2 0 2
Age at VEPTR implantation (y)
Average 7.9 6.8 7.4
Minimum 3.3 1.7 1.7
Maximum 13.5 11.6 13.5
Duration of VEPTR treatment (y)
Average 6.5 6.8 6.7
Minimum 2.3 3.5 2.3
Maximum 10.8 10.5 10.8
No. lengthenings
Average 10 11 10
Minimum 4 5 4
Maximum 16 21 21
EOS indicates early onset scoliosis; VEPTR, vertical expandable prosthetic
titanium rib.
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(range, 10mo to 87mo) with an average major curve’s Cobb
angle of 59 degrees and an average main kyphosis of 58 de-
grees. Final fusion surgery was recommended in 2 of the 12
patients, but after interdisciplinary assessment the patients were
not eligible for surgery because of their severely restricted
cardiopulmonary comorbidities. Main kyphosis angle at the
end of lengthening until latest follow-up did not change in
patients following a nonfusion strategy (P=0.473). The major
curve showed some minor, statistically not signiﬁcant pro-
gression in both, patients with removal of VEPTR (P=0.289),
and patients with VEPTR in situ (P=0.051) (Figs. 1, 2). No
hardware failure occurred in patients following a nonfusion
strategy. Seventeen patients underwent instrumented ﬁnal
fusion surgery. The mean age at the time of ﬁnal fusion was
14.6±1.5 years (range, 11.1 y to 16.7 y), with a mean interval
of 2.1±1.1 years (range, 0.6 y to 4.1 y) between the last
lengthening and the ﬁnal spondylodesis. Compared with the
nonfusion group, patients undergoing ﬁnal fusion surgery had
signiﬁcantly higher average major curve Cobb angle (73 vs. 57
degrees; P=0.04) and main kyphosis angle (85 vs. 54 degrees;
P=0.05) at the end of lengthening, and they were signiﬁcantly
younger at the time of VEPTR implantation (6.2 y vs. 8.7 y;
P=0.005) (Fig. 3). With ﬁnal fusion surgery an average 14%
correction rate of the main coronal deformity was achieved,
but signiﬁcant (P=0.034) loss of correction was present after a
mean follow-up of 31 months (Fig. 1), although, no obvious
implant loosening or breakage appeared. Average main
kyphosis correction rate was only 9% and, although not
statistically signiﬁcant (P=0.085), some loss of correction was
also noted at the latest follow-up (Fig. 2). An analysis of the
subgroups showed that the loss of correction was tendentially
higher in patients with preoperative halo-gravity traction.
Nine patients had one-staged removal of VEPTR
and instrumented spinal fusion surgery. Eight patients had
a staged procedure with VEPTR removal followed by
halo-gravity traction and ﬁnal instrumented spondylod-
esis. The average duration of halo-gravity traction was
27± 11 days (range, 14 to 43 d), and the mean correction
of the main coronal Cobb angle and the main kyphosis
was 11± 5 degrees (range, 1 to 18 degrees; P= 0.631) and
12± 6 degrees (range, 2 to 21 degrees; P= 0.124), re-
spectively.
Overall, 65 complications occurred during VEPTR
treatment, leading to a total of 40 unplanned returns to the
operating room (OR). This corresponds to a mean compli-
cation rate of 1.9 per patient or 0.2 per elective lengthening.
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FIGURE 1. Changes in main coronal Cobb angle after vertical prosthetic titanium rib prosthesis (VEPTR) implantation (= index
surgery), at the end of implant lengthening, after final fusion (if applicable), and at latest follow-up for all VEPTR graduates
(continuous line), and dependent on final treatment strategy (discontinuous lines).
20
30
40
50
60
70
80
90
before index
surgery
after index
surgery
at end of
lengthening
after final
 fusion
at latest 
follow-up
m
a
in
 k
yp
ho
sis
Changes in main kyphosis angle
r/o VEPTR®
VEPTR® in situ
final fusion
all graduates
FIGURE 2. Changes in main kyphosis angle after vertical prosthetic titanium rib prosthesis (VEPTR) implantation (= index surgery),
at the end of implant lengthening, after final fusion (if applicable), and at latest follow-up for all VEPTR graduates (continuous line),
and dependent on final treatment strategy (discontinuous lines).
J Pediatr Orthop  Volume 39, Number 10, November/December 2019
Radiographic Outcome and Complications
of VEPTR Graduates
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. www.pedorthopaedics.com | e733
According to the classiﬁcation system by Smith et al,21 32
complications could be rated as severity grade (SV) I, not
requiring unplanned surgery, 27 complications were SV IIa
requiring a single unplanned trip to the OR, and 6 com-
plications were SV IIb requiring multiple unplanned sur-
geries. Basically, the 3 patients who were excluded because
they died during VEPTR treatment should be rated as SV
IV. Forty-ﬁve of the 65 (69%) complications were implant-
related, representing failure of anchorage (ie, dislocation of
the rib hook) in 91% and rod breakage in 9%; 19 surgical
site infections (SSI) occurred in 11 patients. The overall in-
fection rate during growth sparing treatment was 5.0% (19
infections/381 surgeries, including index operations).
Greater main kyphosis before VEPTR implantation
was the only parameter to show statistically signiﬁcant
correlation (P< 0.001) to a higher number of complications.
There was a 41% (7/17) complication rate in patients
with ﬁnal fusion leading to 6 unplanned returns to the OR,
(35% reoperations). Two patients sustained an implant-related
early SSI (within 2wk ﬁnal fusion surgery), requiring one ad-
ditional surgery each, and antibiotic treatment. In 2 patients
with proximal junctional kyphosis the instrumentation was
extended cranially. One Goldenhar syndrome patient with a
postoperative loss of sagittal balance underwent a single level
pedicle subtraction osteotomy and extension of the ﬁxation to
the pelvis 9 months after ﬁnal fusion (Fig. 4). In one patient
ﬁnal fusion surgery had to be interrupted because of a
malfunction of the ventricular-peritoneal shunt system. One
patient with extensive superﬁcial delayed wound healing did
not require additional surgery.
DISCUSSION
Surgical treatment of EOS represents a challenge for
the patient and his family, as well as for the treating
physician. Apart from the high complication rate and the
psychosocial burden of repetitive hospital stays and sur-
geries, the evolution of the deformity is difﬁcult to predict.
The same applies when it comes to decide on ﬁnal treatment
regimen. Which patients are eligible for a nonfusion strat-
egy, and which patients should undergo ﬁnal fusion surgery?
What is the best moment to cease growth sparing treatment?
The paucity of reliable data and the heterogeneity of
EOS patients harden the decision-making process, and
comorbidities, high complication and reoperation rates,
as well as each individual patient’s and families’ expect-
ations must be respected when developing the ﬁnal
treatment plan.
Most of the time the decision about when to stop
expansions is less surgeon-driven, but rather determined
by curve progression, failure to further distract, or
complications.18,22 Following the progressive natural his-
tory of adolescent idiopathic scoliosis (AIS) with curve
magnitudes of > 40 to 50 degrees Cobb angle at skeletal
maturity,23 the magnitude of the deformity is likely to be
the most important factor to indicate a deﬁnitive spinal
fusion in EOS graduates. This is reﬂected in our patients
and is in consistence with a recent report by Pizones et al18
who stated that performing posterior spinal fusion de-
pends on unacceptable or progressive major curve de-
formity, sagittal misalignment, or complications with
previous implants. Whether or not the etiology of the EOS
plays a role is debatable. In our cohort, only 30% of the
patients with congenital EOS underwent ﬁnal fusion sur-
gery compared to 79% of noncongenital EOS patients.
Other studies also showed higher rates of ﬁnal in-
strumented spondylodesis for patients with noncongenital
EOS,12,14,16 but this could not be conﬁrmed by Pizones
et al18 who reported that patients suffering from con-
genital EOS were more likely to undergo posterior spinal
fusion surgery.
Staged surgery with halo-gravity traction prior to
ﬁnal fusion was rather dependent on the degree of ky-
phosis than coronal plane deformity. To our knowledge,
none of the available articles on EOS graduates provide
further information on the use of halo-gravity traction
before performing ﬁnal fusion surgery. Looking at the
little corrections achieved in our patients, and considering
the huge psychologic and economic impact, the effective-
ness of preoperative halo-gravity traction must be ques-
tioned. We assume that beside the occurrence of
spontaneous fusions of the spine with distraction-based
implants,24 the use of rib-based implants with additional
ossiﬁcations of the thorax and along the implants, as
shown in a multicenter study including our own patients,9
may further explain the low correction potential of
A B C
FIGURE 3. Parameters that reached statistical significance between patients undergoing final fusion surgery and patients following
a nonfusion strategy at the end of VEPTR (vertical expandable prosthetic titanium rib) treatment.
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halo-gravity traction in our graduates. Bacterial implant
colonization, which can be present in up to 47% of
VEPTR patients because of repetitive surgical implant
lengthening can be another reason for choosing a staged
ﬁnal fusion procedure.25
In contrast to “late-onset” pediatric scoliosis surgery
with generally very good deformity correction, the ability
to further correct the spine at the end of growth sparing
surgery is limited. Altered vertebral anatomy with poor
bone quality because of year-long implant-related stress-
shielding,26 in combination with poorly perfused scar tis-
sue and stiff high-grade deformities are the consequences
of repetitive surgical lengthening procedures, making ﬁnal
instrumented fusion surgery in these patients highly de-
manding. In 62% of the growing rod graduates reported
by Flynn et al12 the spine was described as completely stiff,
allowing for > 50% deformity correction in only 15% of
patients. This is consistent with other authors, reporting
on a high degree of rigidity, spontaneous autofusion, and
no signiﬁcant changes with ﬁnal fusion surgery.16,19 The
observed loss of correction after ﬁnal fusion, which was
particularly evident in patients with prior halo-gravity
traction, has not been described in other studies. The ex-
tent to which this can be attributed to a settling of the
bone graft in the absence of any indications for implant
loosening cannot be conclusively assessed. Beside the
limited deformity correction, everyone, including the
patient and parents, must be aware of the high compli-
cation and reoperation rates after ﬁnal instrumented
spondylodesis. Whereas 6 of 17 (35%) of our ﬁnal fusion
patients underwent revision surgery, other authors re-
ported on 20% to 24% of patients requiring additional
surgical procedures after posterior instrumented spinal
fusion.16,17 With a mean time to the ﬁrst reoperation after
the ﬁnal fusion procedure of 2.0 years in the cohort of Poe-
Kochert et al,17 the complication rate of our patients is
likely to increase with only 8 of 17 of them having reached
a minimum 2-year follow-up yet.
The considerable complication rate and the en-
counter of rigid deformities of the spine and the thorax
demand to contemplate the avoidance of ﬁnal fusion
procedures. According to Jain et al,13 the most common
indications for forgoing ﬁnal surgical fusion in growing
rod graduates were satisfactory axial alignment and bal-
ance, no implant-related problems, and minimal gain in
length at the last distraction. But, as with our patients,
there is a lack of mid-term and long-term follow-up of
graduates without ﬁnal fusion and it is likely that some of
these patients will require additional surgery in the future.
Although, this is the largest single-center series re-
porting on VEPTR graduates, the study shares the limi-
tations of retrospective data analysis. Future investigations
should as well focus on patient- or proxy-reported outcome,
especially in regard of health-related quality of life, which
FIGURE 4. Course of an ambulant patient with a Goldenhar syndrome and a syndrome-related early onset scoliosis (EOS). Severe
thoracolumbar kyphoscoliosis before VEPTR implantation (A) could be significantly improved after the index surgery (B), and the
correction was largely maintained at the end of implant lengthening (C). One-staged final fusion surgery was performed with
removal of VEPTR and instrumented spondylodesis from T2 to L5 (D). The alar hooks of the former caudad VEPTR foundation were
left in situ because of relevant sinking in the ilium. At the 6-month follow-up the patient presented with marked loss of sagittal
balance requiring revision surgery (E). Sagittal balance was restored by performing a pedicle subtraction osteotomy at L3 and
extending the distal foundation to the pelvis (F).
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might be of greater importance to each individual patient
than basic radiographic parameters.
CONCLUSIONS
Despite an increasing body of knowledge on graduates
from growth sparing surgical treatment, the ﬁnal strategy
remains controversial and difﬁcult. Age at the time of index
surgery, the severity of the deformity at the end of growth
sparing treatment, as well as coronal and sagittal alignment
appear to be important factors to decide on performing ﬁnal
fusion surgery or not. The limited ability to further correct the
deformity and the high rate of complications and reopera-
tions after instrumented spondylodesis must be considered
and matched with each individual patient’s expectations, and
everyone must be aware that the “ﬁnal” fusion might not be
fruitful nor the last surgery. Therefore, the avoidance of ﬁnal
surgical fusion may represent a viable alternative for some
more moderate forms of EOS. Longer follow-up is needed to
report on the natural history of unfused EOS graduates be-
fore recommending this option.
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